Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression
{{output}}
Background: Reliable biomarkers for predicting disease progression in multiple sclerosis (MS) are crucial for advancing precision medicine and optimising treatment strategies. This study evaluates the predictive potential of seru... ...
